Structural biology of the human papillomavirus
- PMID: 39368462
- DOI: 10.1016/j.str.2024.09.011
Structural biology of the human papillomavirus
Abstract
Human papillomavirus (HPV), known for its oncogenic properties, is the primary cause of cervical cancer and significantly contributes to mortality rates. It also plays a considerable role in the globally rising incidences of head and neck cancers. These cancers pose a substantial health burden worldwide. Current limitations in diagnostic and treatment strategies, along with inadequate coverage of preventive vaccines in low- and middle-income countries, hinder the progress toward the World Health Organization (WHO) HPV prevention and control targets set for 2030. In response to these challenges, extensive research in structural virology has explored the properties of HPV proteins, yielding crucial insights into the mechanisms of HPV infection that are important for the development of prevention and therapeutic strategies. This review highlights recent advances in understanding the structures of HPV proteins and discusses achievements and future opportunities for HPV vaccine development.
Keywords: HPV; cancer; function; structure; vaccine.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
Immune responses to human papillomavirus infection and vaccination.Front Immunol. 2025 Jun 16;16:1591297. doi: 10.3389/fimmu.2025.1591297. eCollection 2025. Front Immunol. 2025. PMID: 40589751 Free PMC article. Review.
-
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3. Lancet Infect Dis. 2015. PMID: 25744474 Free PMC article.
-
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7. Gynecol Obstet Invest. 2025. PMID: 39374596 Free PMC article.
-
Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future.Curr Probl Cancer. 2017 Sep-Oct;41(5):323-327. doi: 10.1016/j.currproblcancer.2017.02.006. Epub 2017 Mar 1. Curr Probl Cancer. 2017. PMID: 28416242
Cited by
-
HSPG-binding peptide Pep19-2.5 is a potent inhibitor of HPV16 infection.Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0157524. doi: 10.1128/aac.01575-24. Epub 2025 Jan 14. Antimicrob Agents Chemother. 2025. PMID: 39807885 Free PMC article.
-
Structural and functional roles of conserved residues of human papillomavirus (HPV) E2 protein and biological consequences.Virol J. 2025 Aug 13;22(1):278. doi: 10.1186/s12985-025-02903-7. Virol J. 2025. PMID: 40804408 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources